• Exelixis and Novartis
-- Biopharm Patent Term Adjustment Based on (B) Delay;
• New FDA Regulations and Their Effect on Existing and Emerging Technologies;
• Cintrifuse: Working with Technology Startups and Developing Cincinnati's Innovation Ecosystem;
• University Intellectual Property: The Tech Transfer Perspective;
• The Exhaustingly Self-Replicating Seeds: Monsanto v. Bowman; and
• Gene: The New Four-Letter Word.
There registration fee for the conference is $125 (CincyIP member), $150 (non-member with CLE), $100 (non-member without CLE), or $25 (students). Those interested in registering can do so here.